|
Delayed
NSE India S.E.
05:44:54 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 165.55 INR | -0.28% |
|
+6.74% | -22.40% |
Company Valuation: Arvee Laboratories (India) Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 259 | 610.5 | 1,253 | 969.8 | 1,580 | 1,565 |
| Change | - | 135.74% | 105.23% | -22.6% | 62.95% | -0.98% |
| Enterprise Value (EV) 1 | 256.9 | 612.9 | 1,238 | 970.8 | 1,572 | 1,526 |
| Change | - | 138.57% | 101.99% | -21.58% | 61.88% | -2.9% |
| P/E | 11.6x | 22.8x | 48.7x | 23.5x | 151x | 72.9x |
| PBR | 1.39x | 2.85x | 5.23x | 3.46x | 5.43x | 5.01x |
| PEG | - | 1.1x | -12.59x | 0.4x | -2x | 1x |
| Capitalization / Revenue | 0.57x | 1.29x | 3.11x | 1.58x | 5.21x | 4.07x |
| EV / Revenue | 0.57x | 1.29x | 3.07x | 1.58x | 5.18x | 3.96x |
| EV / EBITDA | 4.27x | 10.1x | 21.8x | 13.3x | 53.7x | 42.3x |
| EV / EBIT | 6.88x | 16.7x | 36.9x | 18.7x | 109x | 62x |
| EV / FCF | 3.73x | -53.5x | 161x | -361x | 44.3x | -69.3x |
| FCF Yield | 26.8% | -1.87% | 0.62% | -0.28% | 2.26% | -1.44% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 2.02 | 2.43 | 2.336 | 3.738 | 0.95 | 1.949 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 454.2 | 473.8 | 403.3 | 613.5 | 303.5 | 384.9 |
| EBITDA 1 | 60.13 | 60.6 | 56.68 | 72.73 | 29.29 | 36.11 |
| EBIT 1 | 37.32 | 36.62 | 33.56 | 52.02 | 14.39 | 24.62 |
| Net income 1 | 22.27 | 26.77 | 25.74 | 41.19 | 10.52 | 21.47 |
| Net Debt 1 | -2.059 | 2.4 | -14.98 | 1.083 | -8.655 | -38.73 |
| Reference price 2 | 23.50 | 55.40 | 113.70 | 88.00 | 143.40 | 141.99 |
| Nbr of stocks (in thousands) | 11,020 | 11,020 | 11,020 | 11,020 | 11,020 | 11,020 |
| Announcement Date | 8/24/20 | 8/24/21 | 5/26/22 | 8/25/23 | 9/3/24 | 8/30/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 19.13M | ||
| 20.94x | 3.77x | 10.64x | 1.89% | 74.47B | ||
| 13.08x | 0.92x | 7.68x | 4.47% | 50.99B | ||
| 59.75x | 9.66x | 40.97x | 0.92% | 18.02B | ||
| 13.8x | 0.9x | 6.37x | 2.65% | 14.4B | ||
| 13.94x | 0.76x | 5.16x | 2.65% | 10.32B | ||
| 16.06x | 0.72x | 7.92x | 3.04% | 10.26B | ||
| 36.83x | 1.74x | 9.2x | 2% | 9.73B | ||
| 32.47x | 4.43x | 18.97x | 0.36% | 8.09B | ||
| 5.31x | 0.68x | 3.17x | -.--% | 7.29B | ||
| Average | 23.58x | 2.62x | 12.23x | 2% | 20.36B | |
| Weighted average by Cap. | 21.96x | 2.89x | 11.86x | 2.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ARVEE Stock
- Valuation Arvee Laboratories (India) Ltd.
Select your edition
All financial news and data tailored to specific country editions
















